The National Institute on Alcohol Abuse and Alcoholism (NIAAA) is offering a grant for researching and developing medications to treat Alcohol Use Disorder (AUD). This grant aims to support projects advancing promising compounds through the drug development pipeline, including IND requirements and human trials. Both for-profit and not-for-profit entities are encouraged to apply, with a focus on demonstrating significant resource commitment to the project. Animal studies will only be supported if required by the FDA or peer review. Applicants are advised to consult with NIAAA prior to submission. Closing date for applications is February 11, 2019.
Opportunity ID: 310361
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AA-19-005 |
| Funding Opportunity Title: | Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.273 — Alcohol Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 15, 2018 |
| Last Updated Date: | Nov 15, 2018 |
| Original Closing Date for Applications: | Feb 11, 2019 |
| Current Closing Date for Applications: | Feb 11, 2019 |
| Archive Date: | Mar 19, 2019 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments County governments Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Small businesses City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal governments (Federally recognized) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to invite cooperative agreement applications for research that advances promising compounds thorough the drug development pipeline for the treatment of Alcohol Use Disorder (AUD). NIAAA is seeking applications for medications development research projects from both for-profit and not-for-profit entities, including academic institutions, pharmaceutical and biotechnology companies, private and public foundations, small businesses not eligible for the SBIR/STTR program and single entities able to demonstrate significant resource commitment to the proposed project. A resource commitment from a single entity could, for example, consist of salary support for key personnel or production and formulation of clinical trial material. The aim of this FOA is to move candidate compounds through Investigational New Drug (IND) requirements, Phase 1 human safety, tolerability, and dosing studies, and Phase 2 human laboratory and proof-of-concept trials. Within these phases of drug development, each proposed project should have a defined entry and exit point. Finally, this FOA will not support animal studies to prove efficacy of the candidate compound unless required by the Food and Drug Administration or peer review. Applicants are strongly encouraged to contact the NIAAA Division of Medications Development Staff prior to submitting to this FOA. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-19-005.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | FORMS-E | PKG00246248 | Jan 11, 2019 | Feb 11, 2019 | View |
Package 1
Mandatory forms
310361 RR_SF424_2_0-2.0.pdf
310361 PHS398_CoverPageSupplement_4_0-4.0.pdf
310361 RR_OtherProjectInfo_1_4-1.4.pdf
310361 PerformanceSite_2_0-2.0.pdf
310361 RR_KeyPersonExpanded_2_0-2.0.pdf
310361 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
310361 RR_Budget_1_4-1.4.pdf
310361 RR_SubawardBudget30_1_4-1.4.pdf
310361 PHS398_ModularBudget_1_2-1.2.pdf
310361 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
